Safety Trial of 68Ga/177Lu-NRT6020 in FAP-Positive Advanced Solid Tumor Patients

Clinical trial NCT06911489 · RECRUITING

Trial details

NCT number: NCT06911489
Sponsor: Chengdu New Radiomedicine Technology Co. LTD.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor Malignancy

Start date: 2025-11-29
Primary completion: 2027-10-01
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.